Frequent microbiological profile changes are seen in subsequent-revision hip and knee arthroplasty for prosthetic

Robert A McCulloch1, Alex Martin2, Bernadette C Young2

  • 1The Royal National Orthopaedic Hospital, Brockley Hill, Stanmore, Middlesex, HA7 4LP, UK.

PubMed

Insights

In multiply revised hip and knee prosthetic joint infections (PJI), microbial organisms frequently change, with 90% differing by the sixth revision. Empirical antibiotics are crucial, guided by prior drug resistance data, and routine antifungals are not supported.

Area of Science:

  • Orthopaedic Surgery
  • Infectious Diseases
  • Microbiology

Background:

  • Prosthetic joint infection (PJI) often necessitates multiple revision surgeries.
  • Understanding microbial changes in repeat revisions is vital for effective treatment.

Purpose of the Study:

  • To characterize the microbiology of multiply revised hip and knee PJI.
  • To inform antimicrobial therapy strategies for complex revision cases.

Main Methods:

  • Retrospective analysis of patients undergoing repeat-revision total knee replacement (TKR) or total hip replacement (THR) for PJI.
  • Data collected from two UK specialist orthopaedic centres (2011-2019).

Main Results:

  • 106 patients identified with a mean age of 67 years.
  • Significant microbial shifts observed; 90% had different organisms by the sixth revision.
  • Coagulase-negative Staphylococcus (36%) and Staphylococcus aureus (19%) were most common; 53% of organisms were multidrug-resistant.

Conclusions:

  • Microbial profiles in multiply revised PJI cases are dynamic and change significantly over time.
  • Empirical antibiotic selection should consider historical resistance patterns.
  • Routine empirical antifungal use is not recommended based on these findings.

Related Concept Videos